FIELD: medicine, pharmaceutics.
SUBSTANCE: presented group of inventions refers to medicine. What is presented is a method for preventing and treating the diabetes mellitus complications associated with the developing degenerative processes of the nervous tissue, comprising administering a medicine containing a peptide of general formula Pro-Gly-Pro, or a pharmaceutically acceptable salt thereof in effective amounts. There are presented pharmaceutical composition comprising said peptide for the neuroprotective therapy of the complications of diabetes mellitus and the method for preparing it.
EFFECT: group of inventions enables the more effective prevention and treatment of the diabetes mellitus complications associated with the developing degenerative processes of the nervous tissue by the use of the peptide Pro-Gly-Pro, or a pharmaceutically acceptable salt thereof.
9 cl, 2 dwg, 4 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
TREATING VASCULAR COMPLICATIONS OF DIABETES | 2010 |
|
RU2545718C2 |
METHOD FOR PREVENTION AND TREATMENT OF CARBOHYDRATE AND LIPID METABOLISM DISORDER IN METABOLIC SYNDROME AND ENCEPHALOPATHY, USE OF TETRAPEPTIDE AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF SUCH DISORDERS | 2012 |
|
RU2480234C1 |
PEPTIDE FOR MEDICAL TREATMENT OF PANCREATIC DIABETES OF 2ND TYPE AND ITS COMPLICATIONS | 2014 |
|
RU2573933C1 |
DIPEPTIDYLPEPTIDASE-4 INHIBITORS FOR LOCAL OPHTHALMOLOGICAL TREATMENT OF NEURODEGENERATIVE RETINAL DISEASES | 2017 |
|
RU2744878C2 |
METHOD OF TREATING DIABETES IN MAMMALS AND INTRANASAL PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES IN MAMMALS | 2009 |
|
RU2403909C1 |
USE OF RKS INHIBITORS IN DIABETES RELATED COMPLICATIONS | 2007 |
|
RU2447892C2 |
NEW PREVENTIVE AND/OR THERAPEUTIC MEDICATION AGAINST DIABETIC NEUROPATHY | 2008 |
|
RU2465906C2 |
AGENT FOR PROPHYLAXIS AND TREATMENT OF DIABETIC COMPLICATIONS | 1996 |
|
RU2173148C2 |
METHOD OF PRODUCING ORAL PREPARATION OF PROINSULIN C-PEPTIDE | 2009 |
|
RU2413531C2 |
N-[2-HYDROXY-3(1-PIPERIDINYL)-PROPOXY]-PYRIDINE-1-OXYDE-3- CARBOXYIMIDOYL CHLORIDE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND TREATMENT METHOD | 2000 |
|
RU2250901C2 |
Authors
Dates
2013-06-20—Published
2012-03-01—Filed